Administration of L-cysteine hydrochloride to animals prior to the injection of nitrogen mustard (HN2) modifies the severe leukopenia characteristically induced by HN2 (1). However, if the L-cysteine hydrochloride is administered after HN2, even immediately, the leukopenia is not modified. It has not been demonstrated whether the effect of L-cysteine depends upon the presence of certain groups or groupings in the molecule or whether it is the result of non-specific chemical inactivation of HN2. Accordingly, the specificity as well as the mechanism of L-cysteine protection was investigated by correlating the chemical structure of related compounds with their ability to prevent HN2-induced leukopenia.
Administration of L-cysteine hydrochloride to animals prior to the injection of nitrogen mustard (HN2) modifies the severe leukopenia characteristically induced by HN2 (1) . However, if the L-cysteine hydrochloride is administered after HN2, even immediately, the leukopenia is not modified. It has not been demonstrated whether the effect of L-cysteine depends upon the presence of certain groups or groupings in the molecule or whether it is the result of non-specific chemical inactivation of HN2. Accordingly, the specificity as well as the mechanism of L-cysteine protection was investigated by correlating the chemical structure of related compounds with their ability to prevent HN2-induced leukopenia.
METHODS
Several amino acids and sulfhydryl-containing compounds structurally closely related to cysteine, as well as compounds containing various combinations of functional sulfhydryl, amino and carboxyl groups were investigated. Ascorbic acid was also tested because, like the other compounds, it is a strong reducing agent.
In addition to L-cysteine, the compounds investigated were glutathione, D,L-homocysteine, D,L-methionine, L-alanine, D,L-serine, thioglycolic acid, dithiopropanol (BAL), thiomalic acid, thiourea, beta mercapto-ethylamine and ascorbic acid (Table I and Figures 1-4) .
Except for dithiopropanol (BAL), amounts molecularly equivalent to, or greater than the amounts of L-Cysteine which have been found to be effective in preventing HN,-induced leukopenia in rabbits were used (Table I) .
Larger amounts of BAL were not used because of their toxicity. Solutions of these substances were adjusted to pH 6.5 to 7.0 with sodium hydroxide and, with the exception of BAL, were injected either intravenously or intraperitoneally. Dithiopropanol (10 per cent solution of BAL in oil) was administered by intramuscular or intraperitoneal injection. GROUPS Although some of these compounds contain a carboxyl group in addition to the sulfhydryl group, they do not contain an amino group. These compounds fail to prevent the mustard-induced leukopenia. The presence of two free sulfhydryl groups in BAL does not result in protection against the leukopenia induced by nitrogen mustard.
its incubation with ascorbic acid. Chemical interaction between HN2 and most of the compounds studied did not occur at room temperature, but only after incubation at 370 C. for 30 minutes.
In contrast to the results obtained after ad-ministration of the incubated mixtures were those obtained when equivalent amounts of the different compounds were injected prior to the HN2. Only L-cysteine and to a much lesser extent D,L-homocysteine and glutathione were capable of modifying the leukopenia (Table I, Figure 6 ). The average maximum fall in the leukocyte count induced by HN2 was 79.9 per cent of the control counts. When L-cysteine was injected prior to HN2, the average maximum fall in the leukocyte count was 37.5 per cent of the control counts. Injection of equivalent amounts of glutathione and D,L-homocysteine prior to HN2 resulted in an average maximum fall in the leukocyte count of 61.8 and 65.3 per cent of the control counts, respectively.
Injection of equivalent amounts of the other compounds prior to the injection of HN2 resulted in a maximum fall in the leukocyte count ranging from 78.7 to 90.3 per cent of the control counts, compared with the fall of 79.9 per cent with HN2 alone. The most severe leukopenia occurred when either thioglycolic acid, BAL, or methionine was injected prior to HN2 (Table I Iz vent leukopenia reveals that only those compounds which have a sulfhydryl, amino and carboxyl group in close apposition were capable of preventing HN2-induced leukopenia (Figure 1) . Thus, L-cysteine, D,L-homocysteine and glutathione had a definite protective effect. L-CySteine, which has a carboxyl group, a free sulfhydryl group, and an amino group on adjacent carbon atoms, was by far the most effective. D,L-Homocysteine, in which the free sulfhydryl and free amino group are separated by one carbon atom, was much less effective than L-cysteine. It is possible that one of the optical isomers of homocysteine may not be effective in preventing leukopenia and that the decreased protection was due to the presence of an inactive isomer in the D,L mixture of the amino acid. Methylation of the sulfhydryl group in D,L-homocysteine to form D,Lmethionine ( Figure 2 ) resulted in the complete disappearance of any detectable protective effect. Glutathione is composed of one molecule of glutamic acid, one of cysteine, and one of glycine (Figure 1 ).. The partial prevention of HN2-induced leukopenia by glutathione may be attributed to the presence of cysteine in the molecule. Although the amount of glutathione injected contained sufficient cysteine (as a constituent of glutathione) to furnish satisfactory protection, the prevention of leukopenia was much less than that obtained with equivalent amounts of L-cysteine. This may indicate that the conjugation of the amino or carboxyl group, or both, in cysteine to form glutathione resulted in decreased ability to protect against leukopenia, or that the release of cysteine from glutathione in tivo was too slow to furnish optimum protection.
2. The effect of compounds containing zicinal amino and carboxyl groups without an adjacent sulfhydryl group: The injection of compounds containing a free amino and vicinal carboxyl group without a sulfhydryl group resulted, in the absence of any protective effect. Thus, the replacement of the sulfhydryl group in cysteine with an hydroxyl group to form serine or with hydrogen to form alanine (Figure 2 ) resulted in complete failure of protection. Thiourea (NH2, CS -NH2), containing two amino groups without vicinal carboxyl or sulfhydryl groups, was likewise ineffective.
3. The role of free sulfhydryl groups: Compounds containing a free sulfhydryl group without an amino group in close proximity were ineffective also, even though one or two carboxyl groups were adjacent (thioglycolic and thiomalic acid, Figure  3 ). The failure of BAL, which has two vicinal sulfhydryl groups, to manifest a protective effect is further evidence that the presence in itself of sulfhydryl groups is not sufficient to prevent leukopenia.
4. The role of the carboxyl group: The presence of a carboxyl group in addition to vicinal amino and sulfhydryl groups is essential for a protective effect. Thus beta mercaptoethylamine 4 which has the same structural configuration as cysteine without a carboxyl group (Figure 4) does not modify HN2-induced leukopenia. This compound was very toxic, several animals dying within three to four hours following intravenous or intraperitoneal administration. The cause of death in these animals is unknown. No irritation or adverse reaction was noted during the period of injection nor immediately after.
Thus under the conditions of these experiments, neither the reducing potential of a compound, nor the presence by themselves of free carboxyl, sulfhydryl, or amino groups could be correlated with the ability of the compounds studied to prevent leukopenia when injected prior to HN2. Those compounds exhibiting a protective effect uniformly have in common the presence of a closely apposed free sulfhydryl, amino and carboxyl group.
The mechanism by which this specific structural configuration results -in modification of the HN2-induced leukopenia is not known. Fruton and associates (3, 4) have shown that HN2 combines in vitro with the functional groups of many proteins and important biologic substances. They suggested that HN2 may produce its effects by inactivating similar substances in tivo. It may then be postulated that HN2-induced leukopenia results from the inactivation or destruction of some of these substance(s) by HN2 which are essential for normal leukopoiesis, and that L-cysteine or related compounds exert a sparing or protective effect by virtue of competition with HN2.
There is abundant evidence that sulfhydryl-containing compounds are involved in leukopoiesis. It is known, for example, that sulfhydryl compounds are concerned with cell division and growth, that the sulfhydryl content of immature cells is greater than that of mature cells and that the blood sulfhydryl content is low in hypoplastic states (5) . Furthermore, irradiation and, drugs that produce a granulocytopenia also produce a fall in the blood sulfhydryl level. A specific molecular configuration involving sulfhydryl, amino and carboxyl groups may be involved in these phenomena. Thus L-cysteine and related compounds may have a role in leukocyte formation or in abnormal leukopoiesis. Further investigation of the role of cysteine and cysteine analogues in leukocyte metabolism is in progress.
The effect of D-cysteine as compared with L-CySteine was not investigated because of the unavailability of D-cysteine. It has been shown (6) , however, that L-Cysteine can reverse cysteine deficiency produced in rats fed low cysteine diets containing bromobenzene, whereas D-cysteine is ineffective. If D-cysteine were similarly ineffective in preventing the leukopenia induced by HN2, it would be further evidence that the mechanism of the L-cysteine protection is other than that solely of chemical inactivation of HN2 in vivo.
The failure of HN2 to produce leukopenia when injected after incubation in vitro with most of the compounds studied, indicates that the HN2 was inactivated by this process. HN2 undergoes rapid intramolecular rearrangement in aqueous solution to form an imine linkage (7) . In this form it is highly reactive and is capable of alkylating free sulfhydryl, amino and carboxyl groups (3). It is likely that alkylation of these groups in the compounds studied was permitted to take place during direct chemical interaction in vitro, thereby resulting in loss of potency of the HN2. While the reaction efficiency of these compounds was not determined, the protective effect of L-cysteine against leukopenia induced by irradiation indicates that factors such as blood level and solubility may not be involved in the failure of compounds with closely related, structure to prevent leukopenia.
SUMMARY AND CONCLUSIONS 1. The specificity and mechanism of L-cysteine protection against HN2-induced leukopenia were investigated by studying the relationship of structure to ability to prevent leukopenia.
2. Of the compounds studied, only those with vicinal sulfhydryl, amino, and carboxyl groups were capable of modifying HN2-induced leukopenia. L-Cysteine, which has a free sulfhydryl, amino and carboxyl group on adjacent carbon atoms was the most effective in preventing leukopenia. D,L-Homocysteine and glutathione were less effective.
3. Substitution or alteration of either the free sulfhydryl, amino or carboxyl group results in the complete disappearance of any detectable protective effect against HN2-induced leukopenia.
4. Under the conditions of this experiment, neither the reducing action of a compound, nor the presence by themselves of free sulfhydryl, amino or carboxyl groups can be correlated with the ability of the compounds studied to prevent leukopenia when injected prior to nitrogen mustard.
5. The data indicate that the protective effect of L-cysteine and its homologues in vivo does not result solely from inactivation of HN2. It is more likely that L-cysteine protects some substance(s), essential for leukopoiesis, from destruction by HN2.
